Clinical trial
Real-world Ruxolitinib Experience in Polycythemia Vera: REVIEW Study
NCT06251102 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Ruxolitinib Experience in Polycythemia Vera: REVIEW Study
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 31, 2024
- Completion date
- July 31, 2025
- Enrollment
- 153 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.